Within Scuola Superiore Sant’Anna (SSSA), the Istituto di Management (IdM) is active in the field of management in the context of private and public organizations as support to a renewed entrepreneurship, in a synergetic perspective, among business, institutions and research.
IdM is the result of a long-term cultural project with particular reference to the management of innovation, sustainability and health.
During the last decade it has moved its focus towards:
– innovation in its fourfold dimension, technological change, organizational change,
cultural change, political and institutional change
– a strong interdisciplinary approach (first of all, within SSSA)
– the method of action research
– interest in both qualitative and quantitative evidence in support of decision making processes.
To address the impact of the pandemic in Tuscany, Confindustria Toscana has announced measures and additional support for industrial SMEs. Approaches to support companies are evolving in accordance with the UN Agenda 2030 and the European Green Deal. On September 11, 2020, the Institute of Management at Sant’Anna School Pisa has issued a study on the expected impact of the crisis in Tuscany showing the need of firms for new business plans and policy responses to foster resilience
Producing new knowledge is an increasingly complex endeavor. How do scientists decide on what topics to focus their work? A team of researchers affiliated with the Sant’Anna School (the Scuola Superiore Sant’Anna), the Scuola Normale Superiore, the University of Bologna and the Pennsylvania State University addressed this question analyzing data on over three decades of publications (from 1977 to 2009) by a very large sample of physicists. Their results published in the journal Scientific Reports
Researchers of the Sant’Anna School Mes Lab Health System Management and Performance Assessment, Rector Sabina Nuti, Minister of Health Roberto Speranza, and Dr. Domenico Mantoan (Agenas, director general of Sanità della Regione Veneto and the president of the board of Agenzia italiana del farmaco) discussed the study results in 2019 pre-Coronavirus phase. The performance assessment 2019 can provide health care managers with essential information to guide actions for further development of the health system towards a post-Covid-19 “new normality”